gastroenterology & hepatologyformula

Lille Score (Alcoholic Hepatitis)

The Lille score assesses the response to corticosteroid treatment in severe alcoholic hepatitis at day 7. A score >0.45 identifies non-responders in whom steroids should be discontinued to avoid unnecessary infection risk.

inputs

years
seconds

when to use

Calculate at day 7 of prednisolone treatment in patients with severe alcoholic hepatitis (Maddrey DF ≥32). The key decision is whether to continue or stop steroids based on the trajectory of bilirubin from day 0 to day 7.

when not to use

The Lille score is only applicable for patients already on corticosteroids for severe alcoholic hepatitis. It cannot be used at baseline — it requires day 7 data. The bilirubin change (day 0 → day 7) is the core driver of the score; ensure both measurements are available and accurate.

clinical pearls

  • The Lille score is fundamentally about bilirubin trajectory. If bilirubin is falling from day 0 to day 7, the patient is responding. If bilirubin is static or rising despite steroids, the patient is not responding.
  • Lille >0.45 is the key threshold. Above this, continuing steroids adds immunosuppression risk (infection) without mortality benefit. Below this, steroids should be continued for the full 28-day course.
  • The 'Lille window' (0.45–0.56) represents partial non-response where clinical judgement is most important. Consider the trend, overall clinical trajectory, and whether there are other reasons bilirubin may not have fallen (e.g., biliary obstruction, concurrent infection).
  • Some centres use a day 4 Lille calculation to identify early non-responders — preliminary data suggest this may allow earlier decisions, but day 7 remains the validated standard.
  • For patients with Lille >0.45 (non-responders), consider early transplant evaluation where institutional policy allows. The concept of 'early liver transplant for severe alcoholic hepatitis' has gained evidence from French and US studies.